The University of Southampton
University of Southampton Institutional Repository

A randomised, controlled trial of the pulmonary artery catheter in critically ill patients

A randomised, controlled trial of the pulmonary artery catheter in critically ill patients
A randomised, controlled trial of the pulmonary artery catheter in critically ill patients

Objective: To compare the survival and clinical outcomes of critically ill patients treated with the use of a pulmonary artery catheter (PAC) to those treated without the use of a PAC. Design: Prospective, randomised, controlled, clinical trial from October 1997 to February 1999. Setting: Adult intensive care unit at a large teaching hospital. Patients: Two hundred one critically ill patients were randomised either to a PAC group (n=95) or the control group (n=106). One patient in the control group was withdrawn from the study and five patients in the PAC group did not receive a PAC. All participants were available for follow-up. Interventions: Participants were assigned to be managed either with the use of a PAC (PAC group) or without the use of a PAC (control group). Main outcome measures: Survival to 28 days, intensive care and hospital length of stay and organ dysfunction were compared on an intention-to-treat basis and also on a subgroup basis for those participants who successfully received a PAC. Results: There was no significant difference in mortality between the PAC group [46/95 (47.9%)] and the control group [50/106 (47.6)] (95% confidence intervals for the difference -13 to 14%, p>0.99). The mortality for participants who had management decisions based on information derived from a PAC was 41/91 (45%, 95% confidence intervals -11 to 16%, p=0.77). The PAC group had significantly more fluids in the first 24 h (4953 (3140, 7000) versus 4292 (2535, 6049) ml) and an increased incidence of renal failure (35 versus 20% of patients at day 3 post randomisation p<0.05) and thrombocytopenia (p<0.03). Conclusions: These results suggest that the PAC is not associated with an increased mortality.

Critically ill patients, Intention-to-treat, No increased mortality, Pulmonary artery catheter
0342-4642
256-264
Rhodes, Andrew
99296ab8-d95e-4088-a872-8b7d9875224f
Cusack, Rebecca J.
dfb1595f-2792-4f76-ac6d-da027cf40146
Newman, Philip J.
d22bc830-b7c4-4b8e-8c8e-a0f4cd4a45c1
Grounds, Michael R.
7bcc2e92-1d00-4c27-ae88-273e9ae22ed8
Bennett, David E.
43df1916-4a46-46db-9044-b18672f49f06
Rhodes, Andrew
99296ab8-d95e-4088-a872-8b7d9875224f
Cusack, Rebecca J.
dfb1595f-2792-4f76-ac6d-da027cf40146
Newman, Philip J.
d22bc830-b7c4-4b8e-8c8e-a0f4cd4a45c1
Grounds, Michael R.
7bcc2e92-1d00-4c27-ae88-273e9ae22ed8
Bennett, David E.
43df1916-4a46-46db-9044-b18672f49f06

Rhodes, Andrew, Cusack, Rebecca J., Newman, Philip J., Grounds, Michael R. and Bennett, David E. (2002) A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Medicine, 28 (3), 256-264. (doi:10.1007/s00134-002-1206-9).

Record type: Article

Abstract

Objective: To compare the survival and clinical outcomes of critically ill patients treated with the use of a pulmonary artery catheter (PAC) to those treated without the use of a PAC. Design: Prospective, randomised, controlled, clinical trial from October 1997 to February 1999. Setting: Adult intensive care unit at a large teaching hospital. Patients: Two hundred one critically ill patients were randomised either to a PAC group (n=95) or the control group (n=106). One patient in the control group was withdrawn from the study and five patients in the PAC group did not receive a PAC. All participants were available for follow-up. Interventions: Participants were assigned to be managed either with the use of a PAC (PAC group) or without the use of a PAC (control group). Main outcome measures: Survival to 28 days, intensive care and hospital length of stay and organ dysfunction were compared on an intention-to-treat basis and also on a subgroup basis for those participants who successfully received a PAC. Results: There was no significant difference in mortality between the PAC group [46/95 (47.9%)] and the control group [50/106 (47.6)] (95% confidence intervals for the difference -13 to 14%, p>0.99). The mortality for participants who had management decisions based on information derived from a PAC was 41/91 (45%, 95% confidence intervals -11 to 16%, p=0.77). The PAC group had significantly more fluids in the first 24 h (4953 (3140, 7000) versus 4292 (2535, 6049) ml) and an increased incidence of renal failure (35 versus 20% of patients at day 3 post randomisation p<0.05) and thrombocytopenia (p<0.03). Conclusions: These results suggest that the PAC is not associated with an increased mortality.

This record has no associated files available for download.

More information

Published date: 13 February 2002
Keywords: Critically ill patients, Intention-to-treat, No increased mortality, Pulmonary artery catheter

Identifiers

Local EPrints ID: 490140
URI: http://eprints.soton.ac.uk/id/eprint/490140
ISSN: 0342-4642
PURE UUID: 4f28b8d2-a950-4da8-9078-4868b75572c1
ORCID for Rebecca J. Cusack: ORCID iD orcid.org/0000-0003-2863-2870

Catalogue record

Date deposited: 15 May 2024 16:37
Last modified: 16 May 2024 01:53

Export record

Altmetrics

Contributors

Author: Andrew Rhodes
Author: Rebecca J. Cusack ORCID iD
Author: Philip J. Newman
Author: Michael R. Grounds
Author: David E. Bennett

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×